Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hyperfine ( (HYPR) ) has provided an announcement.
On October 15, 2025, Hyperfine, Inc. entered into an underwriting agreement with Lake Street Capital Markets, LLC, to issue and sell 14,000,000 shares of Class A common stock at $1.25 per share, expecting gross proceeds of approximately $17.5 million. The offering, set to close around October 17, 2025, aims to support Hyperfine’s working capital and general corporate purposes, including commercial, manufacturing, and R&D activities, potentially impacting its operational capabilities and market positioning.
The most recent analyst rating on (HYPR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Hyperfine stock, see the HYPR Stock Forecast page.
Spark’s Take on HYPR Stock
According to Spark, TipRanks’ AI Analyst, HYPR is a Neutral.
Hyperfine’s overall stock score is driven by strong technical momentum and positive earnings call insights, indicating potential growth and strategic advancements. However, significant profitability challenges and valuation concerns due to ongoing losses weigh down the score.
To see Spark’s full report on HYPR stock, click here.
More about Hyperfine
Hyperfine, Inc. is a pioneering health technology company that has revolutionized brain imaging with its Swoop® system, the first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system. The company aims to transform global patient care by providing accessible and clinically relevant diagnostic imaging.
Average Trading Volume: 477,094
Technical Sentiment Signal: Buy
Current Market Cap: $172.9M
For an in-depth examination of HYPR stock, go to TipRanks’ Overview page.